Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing

BMJ. 2020 May 19:369:m1565. doi: 10.1136/bmj.m1565.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • 4-Hydroxycoumarins / therapeutic use
  • Adult
  • Aftercare / standards
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / drug therapy
  • England / epidemiology
  • Factor Xa Inhibitors / therapeutic use
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Incidence
  • Indenes / therapeutic use
  • International Normalized Ratio / methods
  • Neoplasms / drug therapy
  • Pyrazoles / therapeutic use
  • Pyridones / therapeutic use
  • Risk Assessment
  • Rivaroxaban / therapeutic use
  • State Medicine / organization & administration*
  • Systematic Reviews as Topic
  • Thrombophilia / blood
  • Thrombophilia / diagnosis*
  • Thrombophilia / drug therapy
  • Thrombophilia / prevention & control
  • Vena Cava Filters / standards
  • Venous Thromboembolism / diagnosis*
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / epidemiology
  • Venous Thromboembolism / mortality
  • Vitamin K / antagonists & inhibitors
  • Vitamin K / therapeutic use

Substances

  • 4-Hydroxycoumarins
  • Anticoagulants
  • Factor Xa Inhibitors
  • Fibrin Fibrinogen Degradation Products
  • Heparin, Low-Molecular-Weight
  • Indenes
  • Pyrazoles
  • Pyridones
  • antivitamins K
  • fibrin fragment D
  • Vitamin K
  • apixaban
  • Rivaroxaban